Junshi Biosciences Signed Co-development Agreement with IMCAS to Advance NAb for COVID-19 Treatment Read more
Ridgeback Biotherapeutics and DRIVE Partner to Develop Clinical Stage Coronavirus Treatment Read more
Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia Read more
IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19 Read more
AskBio Enters Research Collaboration and Licensing Agreement with UNC for Angelman Syndrome Read more
Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Read more